Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
No open-market purchases or sales by Processa Pharmaceuticals, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 18 | 11 | −7 |
| Shares | 1.13M | 106.3K | −1.02M (−90.6%) |
| Value | $376.5K | $251.5K | −$125.0K (−33.2%) |
New holders (4)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 48,601 | $114.9K | 0.75% |
| Bank of America Corp | 160 | $378 | 0.00% |
| Main Street Group, LTD | 100 | $235 | 0.00% |
| Macroview Investment Management LLC | 1 | $3 | 0.00% |
Sold out (11)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 315,410 | $105.5K |
| Geode Capital Management, LLC | 122,033 | $40.8K |
| Spinnaker Trust | 76,865 | $25.7K |
| Coastal Bridge Advisors, LLC | 64,956 | $21.7K |
| Renaissance Technologies LLC | 58,200 | $19.0K |
| State Street Corp | 42,786 | $14.3K |
| Northern Trust Corp | 28,139 | $9.41K |
| McCollum Christoferson Group LLC | 12,500 | $4.18K |
| Courier Capital LLC | 12,000 | $4.01K |
| HRT Financial LP | 11,717 | $3.00K |
| BlackRock Inc. | 293 | $98 |